CVMP opinions on veterinary medicinal productsThe Committee adopted by consensus a positive opinion for a marketing authorisation application for Duotic (betamethasone…

EMA is revising its policy on handling of competing interests of scientific committee members and experts (‘Policy 0044’). Stakeholders are invited to comment on the draft revised…

EMA and the Heads of Medicines Agencies (HMA) have published their draft joint EU network strategy to 2028 for an eight-week public consultation.This is a review and update to the…, “The overarching theme of our updated strategy to 2028 is that of change – rapid, somewhat unpredictable but nonetheless full of promise. It will guide the network as...

Election of new vice-chairThe Management Board elected Rui Santos Ivo, President of the Portuguese National Authority of Medicines and Healthcare Products (INFARMED), as its new…

Review of medicines containing finasteride and dutasteride startedReview assesses data related to suicidal thoughts and behavioursEMA has started a review of medicines containing…, Agenda Agenda of the PRAC meeting 30 September - 03 October 2024DraftReference Number: EMA/PRAC/410474/2024 English (EN…, ...

EMA and the European medicines regulatory network are working to further improve efficiency in the assessment and approval processes for new medicines in the European Union. The…